CYBIN INC. (HELP) Form 6-K — Sep 21, 2026
Helus Pharma (Nasdaq: HELP; Cboe CA: HELP), the commercial operating name of Cybin Inc., announced its participation in the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit. CEO Michael Halstead will take part in a fireside chat on Wednesday, September 23, 2026 at 9:00 a.m. EDT, with a live webcast and replay available on the company's investor relations site.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.